These 26 companies saw over 25% drop in Q3 sales, PAT; are they still worth betting on?

These 26 companies saw over 25% drop in Q3 sales, PAT; are they still worth betting on?

The December quarter show of India Inc though, was broadly in line to slightly better than street expectations, there were exceptions which failed to cheer up investors with good numbers. Around 26 companies, with a market capitalisation of over Rs 2,500 crore, reported atleast 25% year-on-year (YoY) fall in both revenue and profits in the … Read more

On a path to recovery: 4 small and mid cap pharma stocks with an upside potential up to 25 %

On a path to recovery: 4 small and mid cap pharma stocks with an upside potential up to 25 %

Suven Pharmaceuticals Limited is a company that is primarily engaged in providing services to global life science and fine chemical, including custom synthesis, process research and development, scale up and contract manufacturing of intermediates, active pharmaceutical ingredients (APIs) and formulations. Synopsis Pharma as a sector has been under pressure for a very long time. However, … Read more